Life sciences company Aditx Therapeutics, Inc. (ADTX) announced Monday that it has submitted an Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for AditxtScore for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens.
from RTT - Biotech https://ift.tt/2EsfwCS
via IFTTT
No comments:
Post a Comment